0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Diagnostic Imaging Clinical Trials Market Research Report 2024
Published Date: May 2024
|
Report Code: QYRE-Auto-36D15165
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Diagnostic Imaging Clinical Trials Market Insights Forecast to 2029
BUY CHAPTERS

Global Diagnostic Imaging Clinical Trials Market Research Report 2024

Code: QYRE-Auto-36D15165
Report
May 2024
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Diagnostic Imaging Clinical Trials Market Size

The global Diagnostic Imaging Clinical Trials market was valued at US$ 1204 million in 2023 and is anticipated to reach US$ 1819.5 million by 2030, witnessing a CAGR of 6.7% during the forecast period 2024-2030.

Diagnostic Imaging Clinical Trials Market

Diagnostic Imaging Clinical Trials Market

Diagnostic imaging clinical trials address questions about what type of imaging test will best detect disease when it is suspected or will help monitor known disease or monitor a therapy to evaluate whether it is working.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Diagnostic Imaging Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Imaging Clinical Trials.

Report Scope

The Diagnostic Imaging Clinical Trials market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diagnostic Imaging Clinical Trials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diagnostic Imaging Clinical Trials companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Diagnostic Imaging Clinical Trials Market Report

Report Metric Details
Report Name Diagnostic Imaging Clinical Trials Market
Accounted market size in 2023 US$ 1204 million
Forecasted market size in 2030 US$ 1819.5 million
CAGR 6.7%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Radiological Imaging Diagnosis
  • Non-radioactive Imaging Diagnosis
Segment by Application
  • Hospital
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company ICON, Parexel, BioTelemetry, ERT, McLaren, Bioclinica, ProScan Imaging, Radiant Sage, Micron, Inc., Imaging Endpoints, Intrinsic Imaging, Median Technologies
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Diagnostic Imaging Clinical Trials companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Diagnostic Imaging Clinical Trials Market growing?

Ans: The Diagnostic Imaging Clinical Trials Market witnessing a CAGR of 6.7% during the forecast period 2024-2030.

What is the Diagnostic Imaging Clinical Trials Market size in 2030?

Ans: The Diagnostic Imaging Clinical Trials Market size in 2030 will be US$ 1819.5 million.

Who are the main players in the Diagnostic Imaging Clinical Trials Market report?

Ans: The main players in the Diagnostic Imaging Clinical Trials Market are ICON, Parexel, BioTelemetry, ERT, McLaren, Bioclinica, ProScan Imaging, Radiant Sage, Micron, Inc., Imaging Endpoints, Intrinsic Imaging, Median Technologies

What are the Application segmentation covered in the Diagnostic Imaging Clinical Trials Market report?

Ans: The Applications covered in the Diagnostic Imaging Clinical Trials Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Diagnostic Imaging Clinical Trials Market report?

Ans: The Types covered in the Diagnostic Imaging Clinical Trials Market report are Radiological Imaging Diagnosis, Non-radioactive Imaging Diagnosis

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diagnostic Imaging Clinical Trials Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Radiological Imaging Diagnosis
1.2.3 Non-radioactive Imaging Diagnosis
1.3 Market by Application
1.3.1 Global Diagnostic Imaging Clinical Trials Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diagnostic Imaging Clinical Trials Market Perspective (2019-2030)
2.2 Diagnostic Imaging Clinical Trials Growth Trends by Region
2.2.1 Global Diagnostic Imaging Clinical Trials Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Diagnostic Imaging Clinical Trials Historic Market Size by Region (2019-2024)
2.2.3 Diagnostic Imaging Clinical Trials Forecasted Market Size by Region (2025-2030)
2.3 Diagnostic Imaging Clinical Trials Market Dynamics
2.3.1 Diagnostic Imaging Clinical Trials Industry Trends
2.3.2 Diagnostic Imaging Clinical Trials Market Drivers
2.3.3 Diagnostic Imaging Clinical Trials Market Challenges
2.3.4 Diagnostic Imaging Clinical Trials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diagnostic Imaging Clinical Trials Players by Revenue
3.1.1 Global Top Diagnostic Imaging Clinical Trials Players by Revenue (2019-2024)
3.1.2 Global Diagnostic Imaging Clinical Trials Revenue Market Share by Players (2019-2024)
3.2 Global Diagnostic Imaging Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Diagnostic Imaging Clinical Trials Revenue
3.4 Global Diagnostic Imaging Clinical Trials Market Concentration Ratio
3.4.1 Global Diagnostic Imaging Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diagnostic Imaging Clinical Trials Revenue in 2023
3.5 Diagnostic Imaging Clinical Trials Key Players Head office and Area Served
3.6 Key Players Diagnostic Imaging Clinical Trials Product Solution and Service
3.7 Date of Enter into Diagnostic Imaging Clinical Trials Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diagnostic Imaging Clinical Trials Breakdown Data by Type
4.1 Global Diagnostic Imaging Clinical Trials Historic Market Size by Type (2019-2024)
4.2 Global Diagnostic Imaging Clinical Trials Forecasted Market Size by Type (2025-2030)
5 Diagnostic Imaging Clinical Trials Breakdown Data by Application
5.1 Global Diagnostic Imaging Clinical Trials Historic Market Size by Application (2019-2024)
5.2 Global Diagnostic Imaging Clinical Trials Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Diagnostic Imaging Clinical Trials Market Size (2019-2030)
6.2 North America Diagnostic Imaging Clinical Trials Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Diagnostic Imaging Clinical Trials Market Size by Country (2019-2024)
6.4 North America Diagnostic Imaging Clinical Trials Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diagnostic Imaging Clinical Trials Market Size (2019-2030)
7.2 Europe Diagnostic Imaging Clinical Trials Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Diagnostic Imaging Clinical Trials Market Size by Country (2019-2024)
7.4 Europe Diagnostic Imaging Clinical Trials Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diagnostic Imaging Clinical Trials Market Size (2019-2030)
8.2 Asia-Pacific Diagnostic Imaging Clinical Trials Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Diagnostic Imaging Clinical Trials Market Size by Region (2019-2024)
8.4 Asia-Pacific Diagnostic Imaging Clinical Trials Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diagnostic Imaging Clinical Trials Market Size (2019-2030)
9.2 Latin America Diagnostic Imaging Clinical Trials Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Diagnostic Imaging Clinical Trials Market Size by Country (2019-2024)
9.4 Latin America Diagnostic Imaging Clinical Trials Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diagnostic Imaging Clinical Trials Market Size (2019-2030)
10.2 Middle East & Africa Diagnostic Imaging Clinical Trials Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Diagnostic Imaging Clinical Trials Market Size by Country (2019-2024)
10.4 Middle East & Africa Diagnostic Imaging Clinical Trials Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ICON
11.1.1 ICON Company Detail
11.1.2 ICON Business Overview
11.1.3 ICON Diagnostic Imaging Clinical Trials Introduction
11.1.4 ICON Revenue in Diagnostic Imaging Clinical Trials Business (2019-2024)
11.1.5 ICON Recent Development
11.2 Parexel
11.2.1 Parexel Company Detail
11.2.2 Parexel Business Overview
11.2.3 Parexel Diagnostic Imaging Clinical Trials Introduction
11.2.4 Parexel Revenue in Diagnostic Imaging Clinical Trials Business (2019-2024)
11.2.5 Parexel Recent Development
11.3 BioTelemetry
11.3.1 BioTelemetry Company Detail
11.3.2 BioTelemetry Business Overview
11.3.3 BioTelemetry Diagnostic Imaging Clinical Trials Introduction
11.3.4 BioTelemetry Revenue in Diagnostic Imaging Clinical Trials Business (2019-2024)
11.3.5 BioTelemetry Recent Development
11.4 ERT
11.4.1 ERT Company Detail
11.4.2 ERT Business Overview
11.4.3 ERT Diagnostic Imaging Clinical Trials Introduction
11.4.4 ERT Revenue in Diagnostic Imaging Clinical Trials Business (2019-2024)
11.4.5 ERT Recent Development
11.5 McLaren
11.5.1 McLaren Company Detail
11.5.2 McLaren Business Overview
11.5.3 McLaren Diagnostic Imaging Clinical Trials Introduction
11.5.4 McLaren Revenue in Diagnostic Imaging Clinical Trials Business (2019-2024)
11.5.5 McLaren Recent Development
11.6 Bioclinica
11.6.1 Bioclinica Company Detail
11.6.2 Bioclinica Business Overview
11.6.3 Bioclinica Diagnostic Imaging Clinical Trials Introduction
11.6.4 Bioclinica Revenue in Diagnostic Imaging Clinical Trials Business (2019-2024)
11.6.5 Bioclinica Recent Development
11.7 ProScan Imaging
11.7.1 ProScan Imaging Company Detail
11.7.2 ProScan Imaging Business Overview
11.7.3 ProScan Imaging Diagnostic Imaging Clinical Trials Introduction
11.7.4 ProScan Imaging Revenue in Diagnostic Imaging Clinical Trials Business (2019-2024)
11.7.5 ProScan Imaging Recent Development
11.8 Radiant Sage
11.8.1 Radiant Sage Company Detail
11.8.2 Radiant Sage Business Overview
11.8.3 Radiant Sage Diagnostic Imaging Clinical Trials Introduction
11.8.4 Radiant Sage Revenue in Diagnostic Imaging Clinical Trials Business (2019-2024)
11.8.5 Radiant Sage Recent Development
11.9 Micron, Inc.
11.9.1 Micron, Inc. Company Detail
11.9.2 Micron, Inc. Business Overview
11.9.3 Micron, Inc. Diagnostic Imaging Clinical Trials Introduction
11.9.4 Micron, Inc. Revenue in Diagnostic Imaging Clinical Trials Business (2019-2024)
11.9.5 Micron, Inc. Recent Development
11.10 Imaging Endpoints
11.10.1 Imaging Endpoints Company Detail
11.10.2 Imaging Endpoints Business Overview
11.10.3 Imaging Endpoints Diagnostic Imaging Clinical Trials Introduction
11.10.4 Imaging Endpoints Revenue in Diagnostic Imaging Clinical Trials Business (2019-2024)
11.10.5 Imaging Endpoints Recent Development
11.11 Intrinsic Imaging
11.11.1 Intrinsic Imaging Company Detail
11.11.2 Intrinsic Imaging Business Overview
11.11.3 Intrinsic Imaging Diagnostic Imaging Clinical Trials Introduction
11.11.4 Intrinsic Imaging Revenue in Diagnostic Imaging Clinical Trials Business (2019-2024)
11.11.5 Intrinsic Imaging Recent Development
11.12 Median Technologies
11.12.1 Median Technologies Company Detail
11.12.2 Median Technologies Business Overview
11.12.3 Median Technologies Diagnostic Imaging Clinical Trials Introduction
11.12.4 Median Technologies Revenue in Diagnostic Imaging Clinical Trials Business (2019-2024)
11.12.5 Median Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Diagnostic Imaging Clinical Trials Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Radiological Imaging Diagnosis
    Table 3. Key Players of Non-radioactive Imaging Diagnosis
    Table 4. Global Diagnostic Imaging Clinical Trials Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 5. Global Diagnostic Imaging Clinical Trials Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Diagnostic Imaging Clinical Trials Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Diagnostic Imaging Clinical Trials Market Share by Region (2019-2024)
    Table 8. Global Diagnostic Imaging Clinical Trials Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Diagnostic Imaging Clinical Trials Market Share by Region (2025-2030)
    Table 10. Diagnostic Imaging Clinical Trials Market Trends
    Table 11. Diagnostic Imaging Clinical Trials Market Drivers
    Table 12. Diagnostic Imaging Clinical Trials Market Challenges
    Table 13. Diagnostic Imaging Clinical Trials Market Restraints
    Table 14. Global Diagnostic Imaging Clinical Trials Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Diagnostic Imaging Clinical Trials Market Share by Players (2019-2024)
    Table 16. Global Top Diagnostic Imaging Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Imaging Clinical Trials as of 2023)
    Table 17. Ranking of Global Top Diagnostic Imaging Clinical Trials Companies by Revenue (US$ Million) in 2023
    Table 18. Global 5 Largest Players Market Share by Diagnostic Imaging Clinical Trials Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Diagnostic Imaging Clinical Trials Product Solution and Service
    Table 21. Date of Enter into Diagnostic Imaging Clinical Trials Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Diagnostic Imaging Clinical Trials Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Diagnostic Imaging Clinical Trials Revenue Market Share by Type (2019-2024)
    Table 25. Global Diagnostic Imaging Clinical Trials Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Diagnostic Imaging Clinical Trials Revenue Market Share by Type (2025-2030)
    Table 27. Global Diagnostic Imaging Clinical Trials Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Diagnostic Imaging Clinical Trials Revenue Market Share by Application (2019-2024)
    Table 29. Global Diagnostic Imaging Clinical Trials Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Diagnostic Imaging Clinical Trials Revenue Market Share by Application (2025-2030)
    Table 31. North America Diagnostic Imaging Clinical Trials Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 32. North America Diagnostic Imaging Clinical Trials Market Size by Country (2019-2024) & (US$ Million)
    Table 33. North America Diagnostic Imaging Clinical Trials Market Size by Country (2025-2030) & (US$ Million)
    Table 34. Europe Diagnostic Imaging Clinical Trials Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. Europe Diagnostic Imaging Clinical Trials Market Size by Country (2019-2024) & (US$ Million)
    Table 36. Europe Diagnostic Imaging Clinical Trials Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Asia-Pacific Diagnostic Imaging Clinical Trials Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Asia-Pacific Diagnostic Imaging Clinical Trials Market Size by Region (2019-2024) & (US$ Million)
    Table 39. Asia-Pacific Diagnostic Imaging Clinical Trials Market Size by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Diagnostic Imaging Clinical Trials Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Latin America Diagnostic Imaging Clinical Trials Market Size by Country (2019-2024) & (US$ Million)
    Table 42. Latin America Diagnostic Imaging Clinical Trials Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Middle East & Africa Diagnostic Imaging Clinical Trials Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Middle East & Africa Diagnostic Imaging Clinical Trials Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Middle East & Africa Diagnostic Imaging Clinical Trials Market Size by Country (2025-2030) & (US$ Million)
    Table 46. ICON Company Detail
    Table 47. ICON Business Overview
    Table 48. ICON Diagnostic Imaging Clinical Trials Product
    Table 49. ICON Revenue in Diagnostic Imaging Clinical Trials Business (2019-2024) & (US$ Million)
    Table 50. ICON Recent Development
    Table 51. Parexel Company Detail
    Table 52. Parexel Business Overview
    Table 53. Parexel Diagnostic Imaging Clinical Trials Product
    Table 54. Parexel Revenue in Diagnostic Imaging Clinical Trials Business (2019-2024) & (US$ Million)
    Table 55. Parexel Recent Development
    Table 56. BioTelemetry Company Detail
    Table 57. BioTelemetry Business Overview
    Table 58. BioTelemetry Diagnostic Imaging Clinical Trials Product
    Table 59. BioTelemetry Revenue in Diagnostic Imaging Clinical Trials Business (2019-2024) & (US$ Million)
    Table 60. BioTelemetry Recent Development
    Table 61. ERT Company Detail
    Table 62. ERT Business Overview
    Table 63. ERT Diagnostic Imaging Clinical Trials Product
    Table 64. ERT Revenue in Diagnostic Imaging Clinical Trials Business (2019-2024) & (US$ Million)
    Table 65. ERT Recent Development
    Table 66. McLaren Company Detail
    Table 67. McLaren Business Overview
    Table 68. McLaren Diagnostic Imaging Clinical Trials Product
    Table 69. McLaren Revenue in Diagnostic Imaging Clinical Trials Business (2019-2024) & (US$ Million)
    Table 70. McLaren Recent Development
    Table 71. Bioclinica Company Detail
    Table 72. Bioclinica Business Overview
    Table 73. Bioclinica Diagnostic Imaging Clinical Trials Product
    Table 74. Bioclinica Revenue in Diagnostic Imaging Clinical Trials Business (2019-2024) & (US$ Million)
    Table 75. Bioclinica Recent Development
    Table 76. ProScan Imaging Company Detail
    Table 77. ProScan Imaging Business Overview
    Table 78. ProScan Imaging Diagnostic Imaging Clinical Trials Product
    Table 79. ProScan Imaging Revenue in Diagnostic Imaging Clinical Trials Business (2019-2024) & (US$ Million)
    Table 80. ProScan Imaging Recent Development
    Table 81. Radiant Sage Company Detail
    Table 82. Radiant Sage Business Overview
    Table 83. Radiant Sage Diagnostic Imaging Clinical Trials Product
    Table 84. Radiant Sage Revenue in Diagnostic Imaging Clinical Trials Business (2019-2024) & (US$ Million)
    Table 85. Radiant Sage Recent Development
    Table 86. Micron, Inc. Company Detail
    Table 87. Micron, Inc. Business Overview
    Table 88. Micron, Inc. Diagnostic Imaging Clinical Trials Product
    Table 89. Micron, Inc. Revenue in Diagnostic Imaging Clinical Trials Business (2019-2024) & (US$ Million)
    Table 90. Micron, Inc. Recent Development
    Table 91. Imaging Endpoints Company Detail
    Table 92. Imaging Endpoints Business Overview
    Table 93. Imaging Endpoints Diagnostic Imaging Clinical Trials Product
    Table 94. Imaging Endpoints Revenue in Diagnostic Imaging Clinical Trials Business (2019-2024) & (US$ Million)
    Table 95. Imaging Endpoints Recent Development
    Table 96. Intrinsic Imaging Company Detail
    Table 97. Intrinsic Imaging Business Overview
    Table 98. Intrinsic Imaging Diagnostic Imaging Clinical Trials Product
    Table 99. Intrinsic Imaging Revenue in Diagnostic Imaging Clinical Trials Business (2019-2024) & (US$ Million)
    Table 100. Intrinsic Imaging Recent Development
    Table 101. Median Technologies Company Detail
    Table 102. Median Technologies Business Overview
    Table 103. Median Technologies Diagnostic Imaging Clinical Trials Product
    Table 104. Median Technologies Revenue in Diagnostic Imaging Clinical Trials Business (2019-2024) & (US$ Million)
    Table 105. Median Technologies Recent Development
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Diagnostic Imaging Clinical Trials Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Diagnostic Imaging Clinical Trials Market Share by Type: 2023 VS 2030
    Figure 3. Radiological Imaging Diagnosis Features
    Figure 4. Non-radioactive Imaging Diagnosis Features
    Figure 5. Global Diagnostic Imaging Clinical Trials Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 6. Global Diagnostic Imaging Clinical Trials Market Share by Application: 2023 VS 2030
    Figure 7. Hospital Case Studies
    Figure 8. Clinic Case Studies
    Figure 9. Others Case Studies
    Figure 10. Diagnostic Imaging Clinical Trials Report Years Considered
    Figure 11. Global Diagnostic Imaging Clinical Trials Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Diagnostic Imaging Clinical Trials Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Diagnostic Imaging Clinical Trials Market Share by Region: 2023 VS 2030
    Figure 14. Global Diagnostic Imaging Clinical Trials Market Share by Players in 2023
    Figure 15. Global Top Diagnostic Imaging Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Imaging Clinical Trials as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Diagnostic Imaging Clinical Trials Revenue in 2023
    Figure 17. North America Diagnostic Imaging Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Diagnostic Imaging Clinical Trials Market Share by Country (2019-2030)
    Figure 19. United States Diagnostic Imaging Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. Canada Diagnostic Imaging Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Europe Diagnostic Imaging Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Diagnostic Imaging Clinical Trials Market Share by Country (2019-2030)
    Figure 23. Germany Diagnostic Imaging Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. France Diagnostic Imaging Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. U.K. Diagnostic Imaging Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Italy Diagnostic Imaging Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Russia Diagnostic Imaging Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Nordic Countries Diagnostic Imaging Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Asia-Pacific Diagnostic Imaging Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Asia-Pacific Diagnostic Imaging Clinical Trials Market Share by Region (2019-2030)
    Figure 31. China Diagnostic Imaging Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Japan Diagnostic Imaging Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. South Korea Diagnostic Imaging Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Southeast Asia Diagnostic Imaging Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. India Diagnostic Imaging Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Australia Diagnostic Imaging Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Latin America Diagnostic Imaging Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Latin America Diagnostic Imaging Clinical Trials Market Share by Country (2019-2030)
    Figure 39. Mexico Diagnostic Imaging Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Brazil Diagnostic Imaging Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Middle East & Africa Diagnostic Imaging Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Middle East & Africa Diagnostic Imaging Clinical Trials Market Share by Country (2019-2030)
    Figure 43. Turkey Diagnostic Imaging Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Saudi Arabia Diagnostic Imaging Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. ICON Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2019-2024)
    Figure 46. Parexel Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2019-2024)
    Figure 47. BioTelemetry Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2019-2024)
    Figure 48. ERT Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2019-2024)
    Figure 49. McLaren Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2019-2024)
    Figure 50. Bioclinica Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2019-2024)
    Figure 51. ProScan Imaging Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2019-2024)
    Figure 52. Radiant Sage Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2019-2024)
    Figure 53. Micron, Inc. Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2019-2024)
    Figure 54. Imaging Endpoints Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2019-2024)
    Figure 55. Intrinsic Imaging Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2019-2024)
    Figure 56. Median Technologies Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2019-2024)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS